Neurologische aandoeningen Panel ADAR AnalysisAIFM1 selected exon sequencingAIMP1 AnalysisANG AnalysisAPP AnalysisAUTS2 AnalysisBSCL2 AnalysisC9ORF72 Repeat analysisCASK AnalysisCHMP2B AnalysisCLCN2 AnalysisCSF1R AnalysisCTC1 AnalysisCTDP1 AnalysisCTSF AnalysisDJ-1 (PARK7) AnalysisDNM2 AnalysisEGR2 AnalysisEXOSC3 AnalysisFA2H AnalysisFAM126A AnalysisFGD4 AnalysisFIG4 AnalysisFMR1-CGG Repeat analysisFUS AnalysisGARS1 AnalysisGDAP1 AnalysisGJB1 AnalysisGJC2 AnalysisGRN (PGRN) AnalysisHDAC8 AnalysisHEPACAM AnalysisHSPB1 AnalysisHSPB8 AnalysisHSPB8 Analysis (HMN)HSPD1 AnalysisIFIH1 AnalysisIGHMBP2 AnalysisLITAF AnalysisLMNA AnalysisLMNB1 MLPALRRK2 (PARK8) AnalysisLRSAM1 AnalysisMAPT AnalysisMethylering Chr.15q11MFN2 AnalysisMicrodeleties MLPAMPZ AnalysisMTM1 AnalysisMTMR2 AnalysisNDRG1 AnalysisNEFL AnalysisNGF AnalysisNGS Amyotrofe Lateraal Sclerose ALSNGS BewegingsstoornissenNGS Cornelia de LangeNGS DementieNGS Dementie risicofactorenNGS EpilepsieNGS Intellectual disabilityNGS Neurodegeneration with brain iron accumulation NBIANGS Neuropathy/Charcot Marie ToothNGS ParkinsonNGS Pontocerebellaire hypoplasie PCHNGS WittestofziektenNIPBL AnalysisNKX2-1 AnalysisPARKIN (PARK2) AnalysisPCH Volendamse founder mutatiePINK1 (PARK6) AnalysisPLP1 AnalysisPLP1 Del/Dup analysisPMP22 AnalysisPMP22 Del/Dup analysisPOLR1C AnalysisPOLR3A AnalysisPOLR3B AnalysisPRNP AnalysisPSEN1 AnalysisPSEN2 AnalysisRAB7A AnalysisRARS2 AnalysisRNASEH2A AnalysisRNASEH2B AnalysisRNASEH2C AnalysisRNASET2 AnalysisSAMHD1 AnalysisSEPTIN9 AnalysisSETX AnalysisSGCE AnalysisSH3TC2 AnalysisSHANK3 AnalysisSMC1A AnalysisSNCA (PARK1) AnalysisSNORD118 AnalysisSOD1 AnalysisSPTLC1 AnalysisTARDBP AnalysisTHAP1 AnalysisTMEM106B AnalysisTMEM63A AnalysisTOE1 AnalysisTOR1A AnalysisTREX1 AnalysisTRPV4 AnalysisTSEN2 AnalysisTSEN34 AnalysisTSEN54 AnalysisTUBB4A AnalysisUFM1 Select exon sequencingUPD Chr.15VCP AnalysisVRK1 AnalysisWBS MLPAWNK1 Analysis